ISSN: 2375-4273
短いコミュニケーション
Monitoring hypoglycemia and glycaemic variability through CGM devices in type 2 diabetes patients
Metabolic clustering of risk factors: Evaluation of triglyceride-glucose index (TyG index) for evaluation of insulin resistance
Cardiovascular aspects of the patients with diabetes
Would it be advantageous utilizing beta cell therapies over immunotherapies for avoidance of type 1 diabetes - A systematic Review on the role of beta cells in etiopathogenesis of type 1 diabetes along with treatments targeting beta cells or combination therapy would be better
Diabetic kidney disease: Where are we and what does the future hold
Comparison of adverse effects among different GLP-1 receptor agonists added to basal insulin and between GLP-1 receptor agonists and basal Insulin versus basal-plus or basal-bolus insulin in type 2 diabetes
